Other languages Shandong Lukang Pharmaceutical Co.,Ltd.

Equities

600789

CNE000000P61

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
7.14 ^CNY	+10.02%		+15.72%	-.--%

Apr. 23	Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 22	Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23
Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22
Lukang Pharmaceutical Gets Nod to Produce Parkinson's Disease Drug	Jan. 25
Lukang Pharmaceutical's Piperacillin Sodium, Tazobactam Sodium Injection Passes Regulatory Evaluation	Nov. 13
Lukang Pharmaceutical's Ampicillin Sodium and Sulbactam Sodium Pass Regulatory Evaluation	Nov. 02
Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
Lukang Pharmaceutical's Ornidazole Tablets Passes Regulatory Evaluation	23-09-18
Lukang Pharma Generic Hypertension Drug Passes Regulatory Evaluation	23-09-08
Lukang Pharmaceutical's Cefaclor Granules Passes Chinese Drug Regulator's Evaluation	23-09-06
Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18
Lukang Pharmaceutical's Cefminox Sodium for Injection Passes Regulatory Evaluation	23-07-25
Lukang Pharmaceutical's Cefaclor Capsules Passes Regulatory Evaluation	23-07-12
Lukang Pharma's Ampicillin Sodium for Injection Passes Regulatory Evaluation	23-05-09
Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18
Lukang Pharma Gets Nod to Market Anti-Arthritis Drug Ingredient	23-02-23
Lukang Pharma’s Benzyl Alcohol Wins Marketing Approval in China	23-02-09
Shandong Lukang Pharmaceutical Raising 1.2 Billion Yuan to Fund Expansion Plans	23-01-03
Lukang Pharma Gets Regulatory Nod for Anti-Pneumonia Drug	22-12-20
Lukang Pharmaceutical Gets Approval for Diabetes Treatment Tablet	22-11-16
Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shandong Lukang Pharmaceutical Co.,Ltd.

Equities

600789

CNE000000P61

Other languages

Filters